Dr. Roisin Adams is Head of HTA Strategy and External Engagement for the NCPE and Chair of the EU Member State HTA Coordination group.

Dr. Adams led the HTA team for a number of years before being seconded to the HSE to lead a new unit tasked with overseeing and managing high cost drugs in acute hospitals. Dr. Adams was elected as Chair of the Health Technology Assessment Coordination Group for both pharmaceutical and medical device technologies. The HTACG is the governance body responsible for the EU HTA Regulation.  She also co-chairs the HTA domain of the BeNeLuxA initiative and is a Director on the Board of the International Horizon Scanning Initiative. She has been awarded a number of grants from the Health Research Board to examine health preferences in Ireland. Her areas of interest include methods for preference elicitation, combining different data for evidence synthesis and reimbursement mechanisms for high cost drugs. She has held advisory positions for Department of Health, the Health Information and Quality Authority and policy direction at EU level.